ARCHIVES

Lines Drawn Over HHS Appropriations.

This article is from The Cancer Letter archive.

Vol. 33 No. 36 | October 5, 2007

Download PDF Visit The Full Archive

Related Articles

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

December 28, 2012

Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP

June 24, 1994

Lombardi Center, Virgin Islands Collaborate On Patient Care

August 7, 1981

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

NCI Advisory Group, Other Cancer Meetings For May, June

April 30, 1976

Community Assn. Plan Meeting In DC On Program Problems

November 29, 1974